Amphastar Pharmaceuticals (AMPH) Non Operating Income (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Non Operating Income of -$3.6 million for Q1 2026, up 44.36% year-over-year from -$2.5 million in Q1 2025, and up 3.09% quarter-over-quarter from -$3.7 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Non Operating Income (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Non Operating Income history runs 14 years deep, the most recent figure standing at -$3.6 million for Q1 2026.
- In Q1 2026, Non Operating Income rose 44.36% year-over-year to -$3.6 million; the TTM figure through Mar 2026 stood at -$13.9 million (up 36.56% YoY), while the FY2025 annual figure was -$16.8 million, down 7.18% from the prior year.
- Non Operating Income for Q1 2026 stood at -$3.6 million, up from -$3.7 million in the prior quarter.
- The five-year high for Non Operating Income was $7.4 million in Q1 2022, with the low at -$12.6 million in Q4 2023.
- The 5-year median for Non Operating Income is -$3.6 million (2026), against an average of -$3.1 million.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income jumped 242.89% in 2022, then tumbled 4699.25% in 2025.
- Amphastar Pharmaceuticals' Non Operating Income stood at $3.4 million in 2022, then tumbled by 468.58% to -$12.6 million in 2023, then jumped by 90.65% to -$1.2 million in 2024, then sank by 212.35% to -$3.7 million in 2025, then rose by 3.09% to -$3.6 million in 2026.
- Business Quant data shows AMPH's Non Operating Income at -$3.6 million in Q1 2026, -$3.7 million in Q4 2025, and -$3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 949.26 Mn | 659.13 Mn | 93.47 Mn | -1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.19 Mn |
| Mar 31, 2026 | -3.58 Mn |
| Dec 31, 2025 | -3.69 Mn |
| Sep 30, 2025 | -3.81 Mn |
| Jun 30, 2025 | -2.85 Mn |
| Mar 31, 2025 | -6.43 Mn |
| Dec 31, 2024 | -1.18 Mn |
| Sep 30, 2024 | -9.37 Mn |
| Jun 30, 2024 | -4.97 Mn |
| Mar 31, 2024 | -134,000.00 |
| Dec 31, 2023 | -12.64 Mn |
| Sep 30, 2023 | -9.04 Mn |
| Jun 30, 2023 | -4.09 Mn |
| Mar 31, 2023 | 136,000.00 |
| Dec 31, 2022 | 3.43 Mn |
| Sep 30, 2022 | -632,000.00 |
| Jun 30, 2022 | -1.67 Mn |
| Mar 31, 2022 | 7.42 Mn |
| Dec 31, 2021 | 2.91 Mn |
| Sep 30, 2021 | 12.88 Mn |